Jupiter Wellness

Jupiter Wellness, Inc. engages in the development of cannabidiol based medical therapeutics and wellness products. Its product line includes CaniSun, CaniSkin, and CaniDermRx. It operates through the following segments: sales and development of cannabidiol (CBD) based skin care and therapeutic products and sales of merchandise sold to theme parks segments.The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Safety Shot, Inc. engages in the business of developing cannabidiol (CBD) based medical therapeutics and wellness products. It operates under the Sales and Development of CBD Based Skin Care and Therapeutic Products, and Sales and Merchandise Sold to Theme Parks segments. The company was founded by Brian S. John on October 24, 2018 and is headquartered in Jupiter, FL.

https://pubmed.ncbi.nlm.nih.gov/34056830/ JUPITER, FL / ACCESSWIRE / June 22, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced the publication of clinical study results to investigate the safety and efficacy of JW-100 its proprietary lotion formulation for the treatment of atopic dermatitis (eczema). J Cosmet Dermatol 2021 May 31: Online ahead of print.

Results of Clinical Study Showing That JW 100 Significantly Reduces ISGA Score in Atopic Dermatitis (AD) Published

The stock price of Jupiter Wellness, Inc. (NASDAQ: JUPW) increased by over 15% pre-market. This is why it happened.

JUPW Stock Price Increases Over 15% Pre-Market: Why It Happened

JUPITER, FL / ACCESSWIRE / June 17, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a licensing agreement for two patents covering the use of Aspartame for the treatment of Contact Dermatitis. The Agreement signed with the Oklahoma Medical Research Foundation is for a license to two issued patents, US, 7,288,527 and US 7,816,327 which cover the use of aspartame for the treatment of contact dermatitis.

Jupiter Wellness Licenses Patents for the Treatment of Contact Dermatitis

Four Indications in Clinical Development JUPITER, FL / ACCESSWIRE / April 29, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced an update on its clinical pipeline of CBD-based therapeutic topical formulations including JW-100 for the treatment of eczema, JW-200 for skin cancer, JW-300 for burns, and JW-400 for herpes cold sores. Commenced Patient Enrollment for Skin Cancer: Study Completion Expected Q4 2021 Jupiter's JW-200 is designed to provide action and relief in the treatment of Actinic Keratosis (AK), the most common precancer that forms on skin as a result of exposure to ultraviolet (UV) rays.

Jupiter Wellness Advances Clinical Pipeline of CBD-Based Topical Treatments

Accretive acquisition would add a profitable company with approximately $28 million of revenue in 2020 (unaudited) JUPITER, FL / ACCESSWIRE / April 20, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has signed a non-binding Letter of Intent with JustCBD and its affiliates to purchase 51% of JustCBD for $30 million in cash. Per the Letter of Intent, JustCBD would also receive a put option to sell, at its sole discretion, the remaining 49% of JustCBD to Jupiter Wellness for an additional $30 million in a combination of Jupiter Wellness common stock (not to exceed 25% of the outstanding shares of Jupiter) and preferred shares, both valued at $5.00 per share.

Jupiter Wellness Enters into Letter of Intent to Acquire JustCBD and its Affiliates

JUPITER, FL / ACCESSWIRE / April 16, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has appointed Dr. Glynn Wilson as Chief Science Officer, Rich Miller as Chief Compliance Officer, and Ryan Allison as Chief Operating Officer. Over the past quarters, Jupiter has grown its CBD-based consumer wellness business to include 40 products across seven brands in six categories, while also advancing its clinical pipeline with three indications in Phase 1 equivalent studies and one indication ready for an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) based on a successful Phase 1 equivalent which met its primary endpoint.

Jupiter Wellness to Support Growth in CBD-Based Pharma & Consumer Products

JUPITER, FL / ACCESSWIRE / March 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuticals company with 4 significant treatments in skin health for eczema, skin cancer, burns and herpes is pleased to announce that SRM Entertainment is on track for the month of March to produce its highest monthly sales since the wholly owned subsidiary was acquired in December of 2020. SRM designs, manufactures, and sells creative products and services globally to customers including Fortune 500 companies with a focus in the hospitality industry and the world's most iconic theme parks in locations including Orlando, Florida, Southern California, and other high profile cities worldwide.

Jupiter Wellness' SRM Division Sees Significant Monthly Sales Growth as Global Theme Parks Set to Reopen

Ecommerce site is expanded and optimized for Company's growing portfolio of CBD wellness products JUPITER, FL / ACCESSWIRE / March 2, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a CBD-based pharmaceuticals company with 4 significant treatments in skin health for eczema, skin cancer, burns and herpes is pleased to announce the launch of their new e-commerce website. The newly re-designed and user-friendly website; www.CBDcaring.com is a showcase for Jupiter Wellness' Consumer Products Division which features topical skincare brands that are based on natural ingredients and formulated especially for customers seeking therapeutic relief.

Jupiter Wellness Launches New Consumer Products Website: www.cbdcaring.com

Data Expected Q1 2021 From Study of 66 Patients JUPITER, FL / ACCESSWIRE / December 22, 2020 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a leading developer of cannabidiol (CBD) based medical therapeutics and wellness products, today announced it has completed patient enrollment in its clinical study to investigate the efficacy and safety of JW-100 its proprietary lotion formulation for the treatment of atopic dermatitis (eczema). The multi-center, double-blinded, placebo-controlled trial enrolled 66 patients randomized to receive one of three topical formulations including a placebo at least twice per day.

Jupiter Wellness Completes Patient Enrollment in Clinical Study of Novel Cannabidiol Lotion JW-100 for the Treatment of Eczema

News for Jupiter Wellness Stock (JUPW)